|
Name: Mebutamate
Type: Sedative
AKA: Capla
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Mebutamate, a sedative and anxiolytic, was developed in the mid-20th century. It was used to treat anxiety and sleep disorders but has been largely replaced by other medications.
|
|
V. Legal Information
Mebutamate is a sedative-hypnotic used for anxiety and sleep disorders. It is regulated in various countries due to its potential for dependence and abuse. In the United States, it is controlled under similar regulations as other barbiturates. [Source: UNODC].
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Mebutamate is a central nervous system depressant with anxiolytic and sedative effects. It causes sedation and impaired motor function. Short-term use may be effective for managing anxiety and sleep disorders, but long-term use poses risks of dependence and cognitive impairment. Overdose risks include severe sedation and respiratory depression. Safe use involves following prescribed dosages. Recent research explores its efficacy and associated risks.  |
|
VII. Psychological Effects
Mebutamate, an anxiolytic, induces sedation and mood stabilization. Immediate effects include reduced anxiety and mood improvement. Long-term use can lead to dependence, tolerance, and cognitive impairments. Chronic use is associated with mood disorders and potential addiction. Recent studies highlight its effectiveness in reducing anxiety but also emphasize the risks of long-term use and dependence.
 |
|
VIII. Culture
Mebutamate is a sedative and anxiolytic medication, classifying it as a downer. Short-term use reduces anxiety and induces relaxation, while long-term use can lead to dependence and withdrawal symptoms. Overdose risks include severe respiratory depression and potentially fatal outcomes. Safe dosages are medically prescribed, typically under 400 mg per day. Recent research highlights its limited use due to addiction potential. Physical effects include drowsiness, dizziness, and impaired coordination.
 |